Table 2.
Main laboratory findings.
| Parameter (Unit, Normal range) | n = 30, (%) |
|---|---|
| Blood cell counts | |
| White blood cell [WBC] (×109/L, 3.6–10.5) | 16 (53.3) |
| Decreased | 1 (3.3) |
| Increased | 13 (43.3) |
| Lymphocytes (×109/L, 1.1–4) | 7 (23.3) |
| Decreased | 23 (76.7) |
| Neutrophils (×109/L, 1.5–7.7) | 11 (36.7) |
| Increased | 19 (63.3) |
| Haemoglobin (12–18 g/dL) | 14 (46.7) |
| Decreased | 16 (53.3) |
| Platelets (×109/L, 160–400) | 24 (80.0) |
| Decreased | 3 (10.0) |
| Increased | 3 (10.0) |
| Blood biochemistry | |
| Urea (19–49 mg/dL) | 21 (70.0) |
| Decreased | 4 (13.3) |
| Increased | 5 (16.7) |
| Creatinine (0.7–1.3 mg/dL) | 9 (30.0) |
| Decreased | 19 (63.3) |
| Increased | 2 (6.7) |
| Alanine aminotransferase [ALT] (<50 U/L) | 24 (80.0) |
| Increased | 6 (20.0) |
| Aspartate transaminase [AST] (<35 U/L) | 8 (26.7) |
| Increased | 22 (73.3) |
| Lactate dehydrogenase [LDH] (120–246 U/L) | 2 (6.7) |
| Increased | 28 (93.3) |
| Total bilirubin (0.2–1.1 mg/dL) | 28 (93.3) |
| Increased | 2 (6.7) |
| Cardiac enzymes | |
| NT-PRO BNP (<450 ng/L) | 14 (46.7) |
| Increased | 16 (53.3) |
| Troponin I (<45 ng/L) | 25 (83.3) |
| Increased | 5 (16.7) |
| Coagulation parameters | |
| INR (0.8–1.2 INR) | 24 (80.0) |
| Increased | 6 (20.0) |
| D-Dimer (<0.55 mg/L) | 3 (13.3) |
| Increased | 26 (86.7) |
| Fibrinogen (1.7–4.2 g/L) | 1 (3.3) |
| Increased | 29 (96.7) |
| Acute phase reactants | |
| Ferritin (22–322 μg/L) | 16 (53.3) |
| Decreased | 1 (3.3) |
| Increased | 13 (43.3) |
| C-reactive protein concentration [CRP] (0–0.005 g/L) | 9 (30.0) |
| Increased | 21 (70.0) |
| Procalcitonin [PCT] (<0.16 μg/L) | 13 (44.8) |
| Increased | 16 (55.2) |
| Interleukin 6 [IL-6] (0–3.4 pg/mL) | 2 (6.7) |
| Increased | 28 (93.3) |
| APACHE II, mean (SD) | 12.9 (8.0) |
APACHE II: the Acute Physiology and Chronic Health Evaluation II, INR: International normalized ratio, NT-PRO BNP: N-terminal prohormone BNP.